Vanda Pharmaceuticals
VNDA
VNDA
135 hedge funds and large institutions have $934M invested in Vanda Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
54
Reduced
43
Closed
12
Calls
$683K
Puts
$722K
Net Calls
-$39K
Net Calls Change
+$1.13M
Top Buyers
1 |
CCM
1
Consonance Capital Management
New York
|
$87.8M |
2 |
2
First Manhattan
New York
|
$18.2M |
3 |
3
BlackRock
New York
|
$94.5M |
4 |
4
State Street
Boston,
Massachusetts
|
$41.4M |
5 |
5
Macquarie Group
Sydney, NSW 2000,
Australia
|
$48.7M |